Treatment patterns and characteristics of European patients with castration-resistant prostate cancer

BACKGROUND: European treatment guidelines recommend the use of hormonal therapy for the treatment of advanced prostate cancer, including castration-resistant prostate cancer (CRPC), but there is little understanding of how common practices in prostate cancer treatment compare across Europe. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternberg, Cora N, Baskin-Bey, Edwina S, Watson, Mark, Worsfold, Andrew, Rider, Alex, Tombal, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226263/
https://www.ncbi.nlm.nih.gov/pubmed/24206580
http://dx.doi.org/10.1186/1471-2490-13-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226263/
https://www.ncbi.nlm.nih.gov/pubmed/24206580
http://dx.doi.org/10.1186/1471-2490-13-58

Ejemplares similares